Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/18/2014US8673968 Progesterone antagonists
03/18/2014US8673966 ALDH-2 inhibitors in the treatment of addiction
03/18/2014US8673964 Use of drug combinations for treating insulin resistance
03/18/2014US8673963 Method for producing cyclic sulfonic acid ester and intermediate thereof
03/18/2014US8673962 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
03/18/2014US8673960 External liquid preparation containing indomethacin
03/18/2014US8673959 Polymer having indolocarbazole moiety and divalent linkage
03/18/2014US8673958 Fullerene derivatives
03/18/2014US8673957 Fluorescent probe
03/18/2014US8673956 Imido-acid salts and methods of use
03/18/2014US8673955 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
03/18/2014US8673954 Benzimidazole derivatives
03/18/2014US8673953 Compositions and methods for treating purpura
03/18/2014US8673952 Benzoxepin PI3K inhibitor compounds and methods of use
03/18/2014US8673951 Isoxazoline-substituted benzamide compound and pesticide
03/18/2014US8673950 Dihydrooxazol-2-amine derivatives
03/18/2014US8673949 Use of epothilone D in treating Tau-associated diseases including Alzheimer's disease
03/18/2014US8673948 Chemical compounds
03/18/2014US8673947 Enhanced migraine treatments based on ghrelin mimetics
03/18/2014US8673946 4-trimethylammonio-butyrates as CPT2 inhibitors
03/18/2014US8673945 Solid pharmaceutical composition comprising amlodipine and losartan
03/18/2014US8673944 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
03/18/2014US8673943 Fluorinated derivatives of deferiprone
03/18/2014US8673942 Fused ring compounds and use thereof
03/18/2014US8673941 Oxazole derivatives useful as inhibitors of FAAH
03/18/2014US8673940 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
03/18/2014US8673939 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
03/18/2014US8673938 Chemical compounds
03/18/2014US8673937 Eye-drop preparation and use thereof
03/18/2014US8673936 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
03/18/2014US8673935 Drugs for the treatment of sarcogylcanopathies
03/18/2014US8673934 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
03/18/2014US8673933 JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
03/18/2014US8673932 Oxime substituted imidazo-containing compounds
03/18/2014US8673931 Bicyclic heterocyclic spiro compounds
03/18/2014US8673930 Pyrimidylaminobenzamide derivatives for systemic mastocytosis
03/18/2014US8673929 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
03/18/2014US8673928 Compounds and methods for kinase modulation, and indications therefor
03/18/2014US8673927 Uses of DPP-IV inhibitors
03/18/2014US8673926 Spiro[2.4]heptanes for treatment of flaviviridae infections
03/18/2014US8673925 Tyrosine kinase inhibitors
03/18/2014US8673924 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
03/18/2014US8673923 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
03/18/2014US8673921 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
03/18/2014US8673920 Inhibitors of the renal outer medullary potassium channel
03/18/2014US8673919 Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
03/18/2014US8673918 Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators
03/18/2014US8673917 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
03/18/2014US8673916 Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives
03/18/2014US8673915 P 2×4 receptor antagonist
03/18/2014US8673914 Use of phosphodiesterase inhibitors for treating multidrug resistance
03/18/2014US8673913 SHP-2 phosphatase inhibitor
03/18/2014US8673912 Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
03/18/2014US8673911 Inhibitors of histone deacetylase
03/18/2014US8673910 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
03/18/2014US8673909 Indole compounds and methods for treating visceral pain
03/18/2014US8673908 Kynurenine production inhibitor
03/18/2014US8673907 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
03/18/2014US8673906 Chromenone derivatives
03/18/2014US8673905 Imidazo pyrazines
03/18/2014US8673904 Epoxide inhibitors of cysteine proteases
03/18/2014US8673903 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
03/18/2014US8673902 Method of treating otic infections with moxifloxacin compositions
03/18/2014US8673901 Potassium channel blockers
03/18/2014US8673900 Gamma secretase modulators
03/18/2014US8673899 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/18/2014US8673898 Aminodiazepines as toll-like receptor modulators
03/18/2014US8673897 Benzodiazepinone compounds and methods of treatment using same
03/18/2014US8673896 Benzodiazepine and pyridodiazepine derivatives
03/18/2014US8673895 Tetrahydro-pyrimidoazepines as modulators of TRPV1
03/18/2014US8673894 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/18/2014US8673893 Substituted indazole derivatives active as kinase inhibitors
03/18/2014US8673892 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
03/18/2014US8673891 Aminopyrazine derivative and medicine
03/18/2014US8673890 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist
03/18/2014US8673889 BLT2-mediated disease, BLT2 binding agent and the compound
03/18/2014US8673888 Depsipeptide for therapy of kidney cancer
03/18/2014US8673887 Non-hormonal steroid modulators of NF-kB for treatment of disease
03/18/2014US8673886 Use of nifuratel to treat infections caused by Atopobium species
03/18/2014US8673885 Compounds for the protection of sulfur containing linkers in nucleic acid synthesis
03/18/2014US8673884 Anti-influenza compounds
03/18/2014US8673883 Pantothenate derivatives for the treatment of neurologic disorders
03/18/2014US8673882 Inhibitors of autotaxin
03/18/2014US8673881 Compositions and methods for the treatment of inflammation
03/18/2014US8673880 Prevention and/or treatment of neurodegenerative disorders
03/18/2014US8673879 Skin protectant, particularly against hydrophobic (lipophilic) and against hydrophilic (lipophobic) harmful substances
03/18/2014US8673878 Mucosal treatment
03/18/2014US8673877 Use of lactulose in the treatment of autism
03/18/2014US8673876 Pharmaceutical combinations for treatment of specific cancers
03/18/2014US8673871 Compounds and methods for modulating expression ApoB
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673868 Compositions including triciribine and one or more platinum compounds and methods of use thereof
03/18/2014US8673867 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
03/18/2014US8673866 Stabilized formulation for oral administration of therapeutic agents and related methods
03/18/2014US8673865 Agent for enhancing antiseptic power
03/18/2014US8673864 Mangiferin-berberine salt, manufacturing method and use thereof
03/18/2014US8673863 Glutathione-based delivery system
03/18/2014US8673851 Synapse-specific proteins in glomeruli
03/18/2014US8673842 Polypeptoid pulmonary surfactants
03/18/2014US8673594 Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 7860